The C-terminal domain (CTD) in linker histones antagonizes anti-apoptotic proteins to modulate apoptotic outcomes at the mitochondrion

Cell Death Dis. 2014 Feb 13;5(2):e1058. doi: 10.1038/cddis.2014.20.

Abstract

The loss of mitochondrial integrity as a consequence of apoptogenic complexes formed on the outer membrane constitutes a key step in controlling progression of apoptotic cascades. Here, we show that multiple members of the linker histone (LH) family of proteins modify apoptotic cascades initiated by the Bcl-2 protein Bak, and impart resistance to its endogenous antagonist Bcl-xL. Our experiments reveal apoptogenic capabilities equivalent to those documented for H1.2 in H1.1 and H1.3 isoforms. Deletion mutants of H1.2 and site-directed mutagenesis of H1.1 and H1.2 implicated the C-terminal domain in apoptogenic activity. In this context, disruption of protein kinase-C activity using chemical inhibitors, dominant-negative approaches and RNA interference coupled with site-directed modifications in H1.1, identified the protein kinase-Cβ1 isoform as a repressor of H1.1/H1.3 apoptogenic activity. Finally, a H1.2 C-terminal tail recombinant attenuated Bcl-xl inhibition of Bak-induced apoptosis, suggesting that the C-terminal domain was necessary and sufficient for apoptogenic functions. Thus, integration with apoptotic intermediates (via C-terminal tail interactions) may constitute a more generalized function of LH isoforms in apoptotic cascades.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis* / drug effects
  • HEK293 Cells
  • HeLa Cells
  • Histones / genetics
  • Histones / metabolism*
  • Humans
  • Mitochondria / drug effects
  • Mitochondria / metabolism*
  • Mitochondria / pathology
  • Mutagenesis, Site-Directed
  • Mutation
  • Protein Interaction Domains and Motifs
  • Protein Isoforms
  • Protein Kinase C beta / antagonists & inhibitors
  • Protein Kinase C beta / genetics
  • Protein Kinase C beta / metabolism
  • Protein Kinase Inhibitors / pharmacology
  • RNA Interference
  • Signal Transduction
  • Time Factors
  • Transfection
  • bcl-2 Homologous Antagonist-Killer Protein / genetics
  • bcl-2 Homologous Antagonist-Killer Protein / metabolism*
  • bcl-X Protein / genetics
  • bcl-X Protein / metabolism*

Substances

  • BAK1 protein, human
  • BCL2L1 protein, human
  • H1-1 protein, human
  • Histones
  • Protein Isoforms
  • Protein Kinase Inhibitors
  • bcl-2 Homologous Antagonist-Killer Protein
  • bcl-X Protein
  • PRKCB protein, human
  • Protein Kinase C beta